Review reviewHigh

CVE-2023-38955

bioaccess ivs

ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names.

CVSS
7.5
EPSS
0.60%
45.1% percentile
CISA KEV
Not listed
Published
2023.08.03
PRIORITY ASSESSMENT

Review review

The CVSS severity warrants an early asset and exposure review.

Known exploitationNot established by KEV
Exploit probability0.60%
Technical severityCVSS 7.5

Vulnerability overview

ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names.

Affected product and versions

Product
bioaccess ivs
Affected versions
3.3.1
Fixed versions
No verified fixed-version field is available yet

Recommended response sequence

Confirm exposure before applying a vendor-supported change.

Full remediation guide
  1. 1
    Identify

    Confirm that bioaccess ivs and an affected version are present.

  2. 2
    Prioritize

    Combine exploitation signals with asset exposure and business criticality.

  3. 3
    Remediate

    Follow the vendor advisory or supported update path and preserve rollback options.

  4. 4
    Verify

    Recheck the version, service health, access paths, and relevant logs.

Technical data

CVSS vector
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
CWE
CWE-668